THE Society of Hospital Pharmacists of Australia (SHPA) has released a new pharmacy practice standard for treating cardiovascular disease (CVD).
The standard recommends patient to pharmacist ratios, quality improvement indicators specific to specialist cardiology pharmacists, and details how to add innovative, emerging cardiology services to core practice to ensure best care.
SHPA Cardiology Chair, Adam Livori, said the standard highlighted present to future pathways for cardiology pharmacy services.
"These new standards define cardiology pharmacy services, guide implementation and encourage adaptability of models of care to address the dynamic landscape of health care across the system," he said.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 22
